remacemide has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dyker, AG; Lees, KR | 1 |
| Asghar, AU; Hasan, SS; King, AE | 1 |
1 trial(s) available for remacemide and Acute Disease
| Article | Year |
|---|---|
Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
Topics: Acetamides; Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Central Nervous System Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neuroprotective Agents; Placebos | 1999 |
1 other study(ies) available for remacemide and Acute Disease
| Article | Year |
|---|---|
Actions of the anticonvulsant remacemide metabolite AR-R12495AA on afferent-evoked spinal synaptic transmission in vitro and on models of acute and chronic inflammation in the rat.
Topics: Acetamides; Acute Disease; Afferent Pathways; Animals; Animals, Newborn; Anticonvulsants; Chronic Disease; Dizocilpine Maleate; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Hyperalgesia; In Vitro Techniques; Inflammation; Phenethylamines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Nerve Roots; Synaptic Transmission | 2000 |